Sanofi: Venous Thromboembolism trials
The registry lists 13 Venous Thromboembolism studies with Sanofi as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 9Phase 4 1No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With EnoxaparinTerminatedNCT05819125
- A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical IllnessTerminatedNCT05819112
- Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer SurgeryCompletedNCT00723216Phase 3
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture SurgeryCompletedNCT00721760Phase 3
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement SurgeryCompletedNCT00718224Phase 3
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted MobilityTerminatedNCT00714597Phase 3
- Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture SurgeryCompletedNCT00709904Phase 3
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement SurgeryCompletedNCT00697099Phase 3
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing ChemotherapyCompletedNCT00694382Phase 3
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryCompletedNCT00679588Phase 3
- Dose Ranging Study in Elective Total Hip Replacement SurgeryCompletedNCT00338897Phase 2/3
- Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00331838Phase 2
- EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationCompletedNCT00077753Phase 4